Inhibition of lens protein-, endotoxin- and interleukin-1-induced ocular inflammation with osthole and some other non-steroidal anti-Inflammatory agents-Reference-Cited by-同舟云学术

Inhibition of lens protein-, endotoxin- and interleukin-1-induced ocular inflammation with osthole and some other non-steroidal anti-Inflammatory agents

Published:1993-03 Issue:1 Volume:2 Page:5-13
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacology

Author:

Chiou G. C. Y.,Yao Q. S.,Li B. H. P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF02663737.pdf

Reference17 articles.

1. Bhattacherjee P. The role of arachidonate metabolites in ocular inflammation. Prog Clin Biol Res. 1989; 312:211–7.

2. Butler JM, Hammond BR. The effects of sensory denervation on the responses of the rabbit eye to prostaglandin E2 bradykinin and substance P. Br J Pharmacol. 1980;69:495–501.

3. Rubin RM, Samples JR, Rosenbaum JT. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-derived factor antagonist. Arch Ophthalmol. 1988;106:1116–20.

4. Melli M, Parente L. Cytokines and lipocortins in inflammation and differentiation. New York: Wiley-Liss; 1990.

5. Roitt II, Brostoff J, Male DK. Immunology. St Louis; C.V. Mosby;1985.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemistry of natural and synthetic 2H-1-benzopyran-2-ones (coumarins);Fused Pyranones;2024

2. Natural and Synthetic Coumarins with Effects on Inflammation;Molecules;2016-10-02

3. Review: Effects of Nitric Oxide on Eye Diseases and Their Treatment;Journal of Ocular Pharmacology and Therapeutics;2001-04

4. Suppression of Interleukin-1α-Induced Uveitis and Inhibition of Fibroblast-like Cell Proliferation by Synthetic Interleukin-1 Blockers;Journal of Ocular Pharmacology and Therapeutics;1999-08

5. Antagonism of Interleukin-1 (IL-1)-Induced Uveitis with Synthetic IL-1 Blockers;Journal of Ocular Pharmacology and Therapeutics;1997-10